Simon L, Hazard R M, Maher V M, McCormick J J
Carcinogenesis. 1981;2(6):567-70. doi: 10.1093/carcin/2.6.567.
It was shown previously that following treatment with ethylnitrosourea (ENU) SV40-transformed cells from xeroderma pigmentosum patient XP12RO, complementation group A remove O6-ethylguanine from their DNA 2 to 3 times more slowly than do such cells from a normal individual (GM637), but that each of the several other DNA adducts studied are removed at the same rate by both cell lines. If O6-ethylguanine contributes significantly to the cytotoxic effect of ENU, a population which can excise this lesion more rapidly than another during the posttreatment period should exhibit a higher survival. We compared these two cell lines for survival of colony-forming ability following exposure to ENU. XP12RO-SV40 cells proved approximately 3.5-fold more sensitive than GM637. To extend this study to non-transformed diploid human fibroblasts, we compared the survival of cells derived from normal individuals (NF) with that of fibroblasts from several XP patients: XP12BE (group A), XP7BE (group D), and XP4BE (an XP variant). The survival curve of NF, XP7BE, and XP4BE cells, but not XP12BE cells, exhibited a distinct shoulder. The slope of the survival curve for XP12BE cells was 3-fold steeper than that of the exponential part of the curve for NF; the slope of the curve for XP7BE cells, 2-fold steeper; and that of XP4BE cells, 1.7-fold steeper. This enhanced cytotoxicity was not observed in XP12BE cells treated with methylating agents such as methylnitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. We compared NF and XP12BE cells for sensitivity to the mutagenic action of ENU and found approximately 3-fold higher frequencies of 6-thioguanine resistant mutants in the XP cells. This result is expected if the XP cells are slower than normal in excising O6-ethylguanine and if this adduct is mutagenic. When we compared the frequency of mutations induced by ENU and u.v. radiation at doses which caused equal cell killing, ENU was 4-fold more efficient a mutagen than u.v.
先前的研究表明,用乙基硝基亚硝基脲(ENU)处理来自着色性干皮病患者XP12RO(互补组A)的SV40转化细胞后,其从DNA中去除O6-乙基鸟嘌呤的速度比正常个体(GM637)的此类细胞慢2至3倍,但所研究的其他几种DNA加合物在两种细胞系中的去除速度相同。如果O6-乙基鸟嘌呤对ENU的细胞毒性作用有显著贡献,那么在处理后的时期内能够比另一种细胞更快切除该损伤的细胞群体应该表现出更高的存活率。我们比较了这两种细胞系在暴露于ENU后形成集落能力的存活率。结果表明,XP12RO-SV40细胞比GM637细胞敏感约3.5倍。为了将这项研究扩展到未转化的二倍体人成纤维细胞,我们比较了来自正常个体的细胞(NF)与来自几名着色性干皮病患者的成纤维细胞的存活率:XP12BE(A组)、XP7BE(D组)和XP4BE(一种着色性干皮病变体)。NF、XP7BE和XP4BE细胞的存活曲线呈现出明显的肩部,但XP12BE细胞的存活曲线没有。XP12BE细胞存活曲线的斜率比NF曲线指数部分的斜率陡3倍;XP7BE细胞曲线的斜率陡2倍;XP4BE细胞曲线的斜率陡1.7倍。在用甲基化剂如甲基硝基亚硝基脲或N-甲基-N'-硝基-N-亚硝基胍处理的XP12BE细胞中未观察到这种增强的细胞毒性。我们比较了NF和XP12BE细胞对ENU诱变作用的敏感性,发现XP细胞中6-硫代鸟嘌呤抗性突变体的频率大约高3倍。如果XP细胞切除O6-乙基鸟嘌呤的速度比正常细胞慢,并且如果这种加合物具有诱变作用,那么这个结果是可以预期的。当我们比较在引起相同细胞杀伤剂量下ENU和紫外线辐射诱导的突变频率时,ENU作为诱变剂的效率是紫外线的4倍。